Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency
Clinical trial NCT02004691 · COMPLETED
Trial details
- NCT number
- NCT02004691
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-18
- Primary completion
- 2021-03-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.